West Coast Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,240
Closed -$1.85M 87
2025
Q1
$1.85M Hold
2,240
0.21% 62
2024
Q4
$1.73M Sell
2,240
-13
-0.6% -$10.8K 0.19% 63
2024
Q3
$2M Hold
2,253
0.22% 62
2024
Q2
$2.04M Sell
2,253
-1
-0% -$800 0.24% 60
2024
Q1
$1.75M Buy
2,254
+4
+0.2% +$2.85K 0.21% 61
2023
Q4
$1.31M Buy
+2,250
New +$1.31M 0.17% 68

Other funds holding LLY

West Coast Financial's LLY Position: Q2 2025 in Review

West Coast Financial sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 2,240 shares — an estimated $1.85M sold.

West Coast Financial first reported a position in LLY in Q4 2023 and held it in 6 quarters. The position peaked at $2.04M in Q2 2024. 3,908 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • West Coast Financial reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • West Coast Financial sold 2,240 Eli Lilly shares in Q2 2025, an estimated $1.85M.
  • West Coast Financial first reported a position in Eli Lilly in Q4 2023 and held it in 6 quarters.
  • West Coast Financial's Eli Lilly position peaked at $2.04M in Q2 2024.
  • 3,908 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on West Coast Financial's 13F filing for Q2 2025.